This is a past event. Registration is closed. View other NewYorkBIO events.

Event Details

This half day summit hosted at West End Labs will gather professionals from the life science industry as well as the financial sector to discuss hot topics at the intersection of research and development and finance. The afternoon event will feature panel discussions, fireside chats and vision talks focusing on topics such as investment strategies, funding opportunities, and financial trends in the life sciences. The Summit will be followed by a rooftop networking reception overlooking the New York City skyline.

Jun 26, 2024

12:30 PM - 6:30 PM (EDT)

Add to Calendar

West End Labs
West End Avenue 125
New York

Show on map

Agenda

  • 12:30 PM - 1:00 PMRegistration Opens
    1:00 PM - 1:15 PMWelcome Remarks

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO

    1:15 PM - 1:30 PMVision Talk

    Jacqueline Y. Kapur

    CFO at Health2047

    1:30 PM - 2:15 PMPanel Discussion: Women’s Health – Digital Health and Beyond
    Join us for a panel discussion on groundbreaking innovations in women’s health and the current state of the Femtech and quickly growing women’s health ecosystem. In this panel, moderated by Wilson Sonsini Partner Seth Flaum, hear from industry leaders and investors that are pioneering women’s health initiatives and are experts on launching and growing women’s health focused companies, raising capital and investing in this exciting space.

    Seth Flaum

    Partner at Wilson Sonsini Goodrich & Rosati

    Kirthika Parmeswaran

    Founder & CEO of Vital Start Health

    Stephanie Wang

    Investor at FemHealth Ventures

    Lauren Weiniger

    Co-Founder and CEO of The Metapause

    2:15 PM - 2:45 PMFireside Chat

    Shurjo Sen

    Deals Partner at PwC

    Glenn S. Vraniak

    CFO at Inversago Pharma

    2:45 PM - 3:15 PMNetworking Break
    3:15 PM - 4:00 PMPanel Discussion: Perspectives on Financing and M&A Transactions
    Join us for a panel discussion regarding perspectives on financing and M&A transactions, including their outlook on the capital markets as we continue through 2024 and look forward to 2025. Also included in the discussion are specific topics such as IPO transactions, debt and equity financings, collaboration and licensing arrangements, and alternative financing structures.

    Hosted by Deloitte

    Thomas Hoffmann

    Head of Institutional Equities & Corporate Access at H.C. Wainwright

    Mike Lombardo

    Partner at Deloitte

    Randall Stanicky

    CFO at Click Therapeutics

    Karen Krumeich

    CFO at Kazia Therapeutics

    4:00 PM - 4:15 PMVision Talk

    Sean Diver

    Head of East Coast Account Management at Lonza Biologics

    4:15 PM - 4:45 PMFireside Chat

    Bill Harvey

    Executive Vice President at JLL

    Tim Opler

    Managing Director, Biopharma of Stifel

    4:45 PM - 5:00 PMClosing Remarks

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO

    Matthew Malone

    Senior Vice President at Elevate Research Properties

    5:00 PM - 6:30 PMNetworking Reception

Speakers

  • Sean Diver (Head of East Coast  Account Management at Lonza Biologics)

    Sean Diver

    Head of East Coast Account Management at Lonza Biologics

    Read Bio
  • Seth Flaum (Partner at Wilson Sonsini Goodrich & Rosati)

    Seth Flaum

    Partner at Wilson Sonsini Goodrich & Rosati

    Read Bio
  • Bill Harvey (Executive Vice President at JLL)

    Bill Harvey

    Executive Vice President at JLL

    Read Bio
  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO

    Read Bio
  • Thomas Hoffmann (Head of Institutional Equities & Corporate Access at H.C. Wainwright)

    Thomas Hoffmann

    Head of Institutional Equities & Corporate Access at H.C. Wainwright

    Read Bio
  • Jacqueline Y. Kapur (CFO at Health2047)

    Jacqueline Y. Kapur

    CFO at Health2047

    Read Bio
  • Karen Krumeich (CFO at Kazia Therapeutics)

    Karen Krumeich

    CFO at Kazia Therapeutics

    Read Bio
  • Mike Lombardo (Partner at Deloitte)

    Mike Lombardo

    Partner at Deloitte

    Read Bio
  • Matthew Malone (Senior Vice President at Elevate Research Properties)

    Matthew Malone

    Senior Vice President at Elevate Research Properties

  • Tim Opler (Managing Director, Biopharma of Stifel)

    Tim Opler

    Managing Director, Biopharma of Stifel

    Read Bio
  • Kirthika Parmeswaran (Founder & CEO of Vital Start Health)

    Kirthika Parmeswaran

    Founder & CEO of Vital Start Health

    Read Bio
  • Shurjo Sen (Deals Partner at PwC)

    Shurjo Sen

    Deals Partner at PwC

    Read Bio
  • Randall Stanicky (CFO at Click Therapeutics)

    Randall Stanicky

    CFO at Click Therapeutics

    Read Bio
  • Glenn S. Vraniak (CFO at Inversago Pharma)

    Glenn S. Vraniak

    CFO at Inversago Pharma

    Read Bio
  • Stephanie Wang (Investor at FemHealth Ventures)

    Stephanie Wang

    Investor at FemHealth Ventures

    Read Bio
  • Lauren Weiniger (Co-Founder and CEO of The Metapause)

    Lauren Weiniger

    Co-Founder and CEO of The Metapause

    Read Bio

Community

Connect with 151 people attending this event

Tickets

Finance Summit Members Ticket

This ticket is for NewYorkBIO Members only. If you are a member and are having trouble registering please e-mail Alexis Madara at alexis.madara@newyorkbio.org

Member Price $95
Finance Summit Non-Members Ticket

This ticket is for non-members of NewYorkBIO

$195
Finance Summit Investor Ticket

This ticket is for investors who would like to attend the summit and requires approval.

Complimentary
Menu